Year |
Citation |
Score |
2015 |
Zhao X, Parpart S, Takai A, Roessler S, Budhu A, Yu Z, Blank M, Zhang YE, Jia HL, Ye QH, Qin LX, Tang ZY, Thorgeirsson SS, Wang XW. Integrative genomics identifies YY1AP1 as an oncogenic driver in EpCAM(+) AFP(+) hepatocellular carcinoma. Oncogene. PMID 25597408 DOI: 10.1038/Onc.2014.438 |
0.506 |
|
2014 |
Parpart S, Roessler S, Dong F, Rao V, Takai A, Ji J, Qin LX, Ye QH, Jia HL, Tang ZY, Wang XW. Modulation of miR-29 expression by α-fetoprotein is linked to the hepatocellular carcinoma epigenome. Hepatology (Baltimore, Md.). 60: 872-83. PMID 24798303 DOI: 10.1002/Hep.27200 |
0.753 |
|
2014 |
Funamizu N, Lacy CR, Parpart ST, Takai A, Hiyoshi Y, Yanaga K. MicroRNA-301b promotes cell invasiveness through targeting TP63 in pancreatic carcinoma cells. International Journal of Oncology. 44: 725-34. PMID 24398967 DOI: 10.3892/Ijo.2014.2243 |
0.618 |
|
2014 |
Parpart ST, Roessler S, Dong F, Rao V, Ji J, Qin L, Ye Q, Tang Z, Jia H, Wang XW. Abstract 5183: Modulation of miR-29 expression by alpha-fetoprotein is linked to the hepatocellular carcinoma epigenome Cancer Research. 74: 5183-5183. DOI: 10.1158/1538-7445.Am2014-5183 |
0.758 |
|
2013 |
Parpart S, Wang XW. microRNA Regulation and Its Consequences in Cancer. Current Pathobiology Reports. 1: 71-79. PMID 23420713 DOI: 10.1007/S40139-012-0002-7 |
0.342 |
|
2013 |
Parpart S, Roessler S, Dong F, Rao V, Loffredo C, Wang XW. Abstract 3143: A functional interaction between alpha-fetoprotein and miRNA-29 modulates the HCC epigenome. Cancer Research. 73: 3143-3143. DOI: 10.1158/1538-7445.Am2013-3143 |
0.5 |
|
2011 |
Parpart S, Roessler S, Dong F, Rao V, Loffredo C, Wang XW. Abstract C20: The epigenomic fingerprint of hepatocellular carcinoma Cancer Research. 71. DOI: 10.1158/1538-7445.Fbcr11-C20 |
0.761 |
|
Show low-probability matches. |